Illumina, Inc. vs ZIM Integrated Shipping Services Ltd — how do they compare? Illumina, Inc. trades at $278.99 (market cap $39.95B), while ZIM Integrated Shipping Services Ltd trades at $29.96 (market cap $3.65B). The key difference: Illumina, Inc. is far larger — about 10.9× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| ILMN | ZIM | |
|---|---|---|
Market Cap | $39.95B | $3.65B |
Volume | 3,169,503 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $293.69 | $30.51 |
52-Week Low | $91.00 | $12.44 |
Typical Hold Time | 83 Days | 27 Days |
Enterprise Value | $41.31B | $7.32B |
Dividend Yield | — | 20.16% |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $278.17, up 3.89% today and near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent inclusion in the S&P 500 and positive analyst upgrades reflect growing institutional confidence. Revenue remains stable at $4.34B for 2025 with improved profitability, delivering $850M net income after previous losses.
The outlook remains positive with sequencing growth and AI initiatives driving momentum, though elevated valuation ratios and China market headwinds present risks. Analyst consensus leans bullish with 54% buy ratings, but the current price exceeds the $241 consensus target, suggesting near-term consolidation potential before further upside.
ZIM trades at $30.12, up 0.43% on the day and near its 52-week high of $30.96, reflecting strong momentum. The technical outlook is bullish, supported by moving averages, while fundamentals show mixed signals with a low P/S of 0.57 and EV/EBITDA of 3.81, but declining profitability margins. Recent Q2 2026 earnings beat expectations with EPS of $0.53 versus a forecasted loss, though revenue and net income are trending lower year-over-year. Key news includes a pending $35 per share acquisition offer from Hapag-Lloyd, subject to Israeli government approval, creating significant event-driven uncertainty.
The investment case hinges on the acquisition outcome; approval could deliver immediate upside to $35, while rejection may pressure shares despite operational improvements. Risks include earnings volatility, geopolitical factors affecting the deal, and exposure to cyclical shipping rates. Analyst sentiment is cautious with no buy ratings, reflecting the binary nature of the takeover situation. The stock offers value on a sales basis but requires careful risk management due to the high-stakes merger dynamics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →